soul trial oral semaglutide cardiovascular outcomes 2024 nejm found to lower risk of heart failure events in people with type 2 diabetes The impact of oral semaglutide

Its specialty medicines address specific conditions, including respiratory diseases, oncology, and central nervous system (CNS) disorders

Baseline testing may include: A1C and fasting glucose to assess insulin sensitivity Lipid panel to evaluate cardiovascular risk Basic metabolic panel to review kidney function and electrolyte balance Liver function tests to identify any concerns that could affect medication use Thyroid function tests to detect hypothyroidism or other endocrine issues Additional labs as indicated by medical history or symptoms These tests help ensure that patients are receiving the right medication at the right dose

D'Alessandro A, Boeckelmann I, Hammwhner M, et al

Astrocyte senescence promotes glutamate toxicity in cortical neurons